Tricellulin is regulated via interleukin 13 receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis

DSpace/Manakin Repository

Tricellulin is regulated via interleukin 13 receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis

Citable link to this page

 

 
Title: Tricellulin is regulated via interleukin 13 receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis
Author: Krug, SM; Bojarski, C; Fromm, A; Lee, IM; Dames, P; Richter, JF; Turner, JR; Fromm, M; Schulzke, JD

Note: Order does not necessarily reflect citation order of authors.

Citation: Krug, SM, C Bojarski, A Fromm, IM Lee, P Dames, JF Richter, JR Turner, M Fromm, and JD Schulzke. 2017. “Tricellulin is regulated via interleukin 13 receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis.” Mucosal immunology :10.1038/mi.2017.52. doi:10.1038/mi.2017.52. http://dx.doi.org/10.1038/mi.2017.52.
Full Text & Related Files:
Abstract: In the two inflammatory bowel diseases, ulcerative colitis (UC) and Crohn’s disease (CD), altered expression of tight junction (TJ) proteins leads to an impaired epithelial barrier including increased uptake of luminal antigens supporting the inflammation. Here we focused on regulation of tricellulin, a protein of the tricellular TJ essential for the barrier against macromolecules, and hypothesized a role in paracellular antigen uptake. We report that tricellulin is downregulated in UC, but not in CD, and that its reduction increases the passage of macromolecules. Using a novel visualization method, passage sites were identified at TJ regions usually sealed by tricellulin. We show that interleukin-13 (IL-13), beyond its known effect on claudin-2, downregulates tricellulin expression. These two effects of IL-13 are regulated by different signaling pathways: The IL-13 receptor α1 upregulates claudin-2, while IL-13 receptor α2 downregulates tricellulin. We suggest to target the α2 receptor in future developments of therapeutical IL-13-based biologicals.
Published Version: doi:10.1038/mi.2017.52
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730503/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34651926
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters